Northern Trust Corp Arcturus Therapeutics Holdings Inc. Transaction History

Northern Trust Corp

$658 Billion
Q1 2025

A detailed history of Northern Trust Corp transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Northern Trust Corp holds 250,051 shares of ARCT stock, worth $3.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

250,051

Previous 256,332 2.45%

Holding current value

$3.17 Million

Previous $4.35 Million 39.11%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$10.59 - $20.83 $66,515 - $130,833	-6,281 Reduced 2.45%	250,051 $2.65 Million
Q4 2024 Feb 14, 2025	BUY	$14.82 - $25.48 $201,285 - $346,069	13,582 Added 5.6%	256,332 $4.35 Million
Q3 2024 Nov 13, 2024	BUY	$18.08 - $25.38 $224,824 - $315,600	12,435 Added 5.4%	242,750 $5.63 Million
Q2 2024 Aug 14, 2024	SELL	$24.35 - $44.39 $161,367 - $294,172	-6,627 Reduced 2.8%	230,315 $5.61 Million
Q1 2024 May 14, 2024	SELL	$31.23 - $42.99 $314,080 - $432,350	-10,057 Reduced 4.07%	236,942 $8 Million
Q4 2023 Feb 13, 2024	BUY	$17.71 - $32.97 $322,941 - $601,207	18,235 Added 7.97%	246,999 $7.79 Million
Q3 2023 Nov 13, 2023	BUY	$25.44 - $37.35 $23,150 - $33,988	910 Added 0.4%	228,764 $5.84 Million
Q2 2023 Aug 11, 2023	BUY	$23.94 - $32.36 $375,427 - $507,469	15,682 Added 7.39%	227,854 $6.53 Million
Q1 2023 May 15, 2023	SELL	$14.72 - $23.97 $15,985 - $26,031	-1,086 Reduced 0.51%	212,172 $5.09 Million
Q4 2022 Feb 13, 2023	BUY	$14.14 - $23.06 $82,902 - $135,200	5,863 Added 2.83%	213,258 $3.62 Million
Q3 2022 Nov 14, 2022	SELL	$13.05 - $22.13 $19,588 - $33,217	-1,501 Reduced 0.72%	207,395 $3.07 Million
Q2 2022 Aug 12, 2022	BUY	$12.26 - $31.17 $186,192 - $473,378	15,187 Added 7.84%	208,896 $3.29 Million
Q1 2022 May 13, 2022	SELL	$17.64 - $39.57 $148,934 - $334,089	-8,443 Reduced 4.18%	193,709 $5.22 Million
Q4 2021 Feb 08, 2022	SELL	$34.2 - $47.56 $106,635 - $148,292	-3,118 Reduced 1.52%	202,152 $7.48 Million
Q3 2021 Nov 15, 2021	SELL	$27.88 - $58.25 $857,839 - $1.79 Million	-30,769 Reduced 13.04%	205,270 $9.81 Million
Q2 2021 Aug 13, 2021	SELL	$25.79 - $42.11 $212,999 - $347,786	-8,259 Reduced 3.38%	236,039 $7.99 Million
Q1 2021 May 12, 2021	SELL	$38.75 - $86.92 $1.63 Million - $3.66 Million	-42,074 Reduced 14.69%	244,298 $10.1 Million
Q4 2020 Feb 11, 2021	BUY	$34.61 - $123.66 $1.5 Million - $5.37 Million	43,457 Added 17.89%	286,372 $12.4 Million
Q3 2020 Nov 16, 2020	BUY	$37.49 - $63.19 $1.05 Million - $1.77 Million	27,992 Added 13.02%	242,915 $10.4 Million
Q2 2020 Aug 14, 2020	BUY	$12.66 - $58.27 $2.25 Million - $10.3 Million	177,363 Added 472.21%	214,923 $10 Million
Q1 2020 May 14, 2020	BUY	$9.31 - $18.26 $8,658 - $16,981	930 Added 2.54%	37,560 $510,000
Q4 2019 Feb 14, 2020	BUY	$8.93 - $12.41 $124,118 - $172,486	13,899 Added 61.15%	36,630 $398,000
Q3 2019 Nov 13, 2019	BUY	$8.8 - $14.5 $200,032 - $329,599	22,731 New	22,731 $233,000

Others Institutions Holding ARCT

# of Institutions

161

Shares Held

26.5M

Call Options Held

312K

Put Options Held

96.5K

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $337M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Arcturus Therapeutics Holdings Inc. Transaction History